Decoded: The Future of Health with Marwan AbdulAziz Janahi скачать в хорошем качестве

Decoded: The Future of Health with Marwan AbdulAziz Janahi

Join us on Decoded: The Future of Health with hosts, Dr. Vinod Gauba and Alex Kummerman, as we dive into the educational side of Longevity science with Marwan Abdulaziz Janahi. Guest Bio: Marwan Abdulaziz Janahi is a visionary trailblazer in biotechnology and a key architect of Dubai’s industrial strategy for pharmaceuticals and healthcare. He serves as the Senior Vice President of Dubai Science Park and Head of Dubai Knowledge Park and Dubai Academic City. Marwan has been instrumental in positioning Dubai as a global leader in science and innovation. Through his leadership, he champions cutting-edge advancements in regenerative medicine, genomics, and personalized healthcare, while spearheading initiatives to enhance research, local manufacturing, and talent development in the region. He is a thought leader and pioneer in the domain of science and technology and biotechnology. His personal journey, sparked by a health episode in 2011, drew him into the aspects of science that impact human life and longevity, giving him a keen interest in the R&D behind companies making a change in human life Key conversation points & messages: The discussion highlights Dubai's approach to becoming a global leader in biotech by acting as a hub for exchanging ideas, trade, and knowledge, constantly reinventing itself. Marwan explains how Dubai Science Park and other free zones were established to enable the ecosystem, initially by attracting companies with solutions and products to meet the region's healthcare needs, effectively going from market to bench. The conversation addresses the perception of relaxed regulations in Dubai, clarifying that while regulations are rigorous, the leadership is responsive to the needs of the ecosystem to facilitate growth and innovation. Key policy changes fostering innovation include the Golden Visa for long-term vision in life sciences and the development of specialized facilities and a supportive ecosystem for businesses of all sizes. The importance of attracting talent through universities and providing grants for research and validation of ideas to bring them to market is emphasized. The discussion also touches upon Dubai's potential as an exporter of novel therapeutic agents, noting the existing logistics infrastructure and increasing investment and appetite in life sciences, partly accelerated by the focus on clinical trials during Covid-19. Key takeaways: Dubai's agility in adapting regulatory processes and infrastructure is key to its burgeoning biotech ecosystem. The city offers a supportive environment for startups and established companies in healthcare, digital health, medtech, prevention, and AI, serving as a launchpad for expansion into the wider region. The focus on attracting top universities, professors, and students, coupled with grant systems, is driving the transition from publications to marketable innovations. Collaboration is a central theme, with Dubai Science Park actively sparking conversations and bringing people together to solve problems and innovate. The increasing investment and improving infrastructure for clinical trials indicate Dubai is close to becoming a significant innovator and exporter of novel therapeutic agents.